Chemical Structure : GNE-0011
CAS No.: 2413382-30-4
Catalog No.: PC-21848Not For Human Use, Lab Use Only.
GNE-0011 is a monovalent, JQ1-based BRD4 degrader that is not linked to an E3 ligase binder, triggers proteasomal and ubiquitin-dependent selective degradation of BRD4 over BRD2 and BRD3.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $98 | In stock | |
10 mg | $148 | In stock | |
25 mg | $268 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
GNE-0011 is a monovalent, JQ1-based BRD4 degrader that is not linked to an E3 ligase binder, triggers proteasomal and ubiquitin-dependent selective degradation of BRD4 over BRD2 and BRD3.
GNE-0011 shows low nanomolar inhibition of c-Myc in cells (IC50 = 2 nM).
GNE-0011 shows anticance efficacy in a mouse xenograft model (EOL-1) at low doses (3 mg/kg QD IP).
The mechanism by which this monovalent pan-BET binder leads to selective BRD4 degradation is not fully understood.
M.Wt | 475.61 | |
Formula | C26H29N5O2S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
tert-butyl (S)-2-(4-(4-(3-aminoprop-1-yn-1-yl)phenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)acetate |
1. Blake, R. A. Abstract 4452: GNE-0011, a novel monovalent BRD4 degrader. Cancer Res. 79, 4452 (2019).
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright